Zobrazeno 1 - 10
of 117
pro vyhledávání: '"Mitsuhiro Mori"'
Autor:
Michael Karbiener, Maria R. Farcet, Andreas Zollner, Taisei Masuda, Mitsuhiro Mori, Alexander R. Moschen, Thomas R. Kreil
Publikováno v:
npj Vaccines, Vol 7, Iss 1, Pp 1-3 (2022)
Abstract SARS-CoV-2 neutralizing antibodies have been suggested to reflect the efficacy of COVID-19 vaccines. This study reports the direct comparison of the SARS-CoV-2 neutralizing antibody response elicited by a protein- (NVX-CoV2373), an mRNA- (Co
Externí odkaz:
https://doaj.org/article/a4b35fd63a3c4dd5af520e8f841d0a55
Autor:
Kenji Kuriyama, Kyoko Murakami, Taisei Masuda, Kenkichi Sugiura, Sho Sakui, Ron P. Schuring, Mitsuhiro Mori
Publikováno v:
Vaccine.
Publikováno v:
Cement Science and Concrete Technology. 75:332-339
Autor:
Takayuki Hirono, Mitsuhiro Morita, Takehiro Michikawa, Risa Tobe, Takao Tobe, Koki Kato, Soya Kawabata, Akihito Oya, Yusuke Kawano, Kazue Hayakawa, Shinjiro Kaneko, Morio Matsumoto, Masaya Nakamura, Shigeki Yamada, Nobuyuki Fujita
Publikováno v:
BMC Geriatrics, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Managing medication use in older orthopedic patients is imperative to extend their healthy life expectancy in an aging society. However, the actual situation regarding polypharmacy, the intake of potentially inappropriate medicati
Externí odkaz:
https://doaj.org/article/93009ecb1e2f428b9452700659c5506a
Publikováno v:
International Workshop on Advanced Imaging Technology (IWAIT) 2022.
Publikováno v:
Vaccine. 40(24)
We evaluated the safety and immunogenicity of NVX-CoV2373, a recombinant SARS-CoV-2 nanoparticle vaccine, in healthy Japanese participants.This phase 1/2, randomized, observer-blind, placebo-controlled trial conducted in Japan (two sites), enrolled h
Autor:
Taisei Masuda, Kyoko Murakami, Kenkichi Sugiura, Sho Sakui, Ron Philip Schuring, Mitsuhiro Mori
Publikováno v:
Vaccine. 40(13)
The mRNA vaccine, mRNA-1273/TAK-919, encodes the prefusion-stabilised spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We report interim results of the first study evaluating safety and immunogenicity of mRNA-1273 in hea
Autor:
Naoki HORIKOSHI, Atsuya KOMORI, Nobuaki SUZUKI, Mitsuhiro MORI, Masayuki ISHII, Kazuhiro UENO
Publikováno v:
Journal of Japan Society of Civil Engineers, Ser. A1 (Structural Engineering & Earthquake Engineering (SE/EE)). 78:II_29-II_41
Autor:
Takumi Taniguchi MD, Risa Inagaki PharmD, Takehiro Michikawa MD, Soya Kawabata MD, Masahiro Yoshida MD, Yusuke Kawano MD, Mitsuhiro Morita MD, Kazue Hayakawa MD, Mitsunaga Iwata MD, Shigeki Yamada PhD, Nobuyuki Fujita MD
Publikováno v:
Geriatric Orthopaedic Surgery & Rehabilitation, Vol 15 (2024)
Introduction Fractures are often caused by falls in older people. Among various causes of falls, polypharmacy is known to be a risk of falls. Furthermore, potentially inappropriate medicines (PIMs), which interact with polypharmacy, include the drugs
Externí odkaz:
https://doaj.org/article/6a870beb086745b4954909c984f06220
Autor:
Kenji Koneri, Takanori Goi, Hokahiro Katayama, Noriyuki Tagai, Michiaki Shimada, Hidetaka Kurebayashi, Katsuji Sawai, Mitsuhiro Morikawa, Masato Tamaki, Yasuo Hirono, Satomi Hatta, Yoshiaki Imamura, Makoto Murakami
Publikováno v:
Surgical Case Reports, Vol 9, Iss 1, Pp 1-8 (2023)
Abstract Background Follicular cholangitis (FC) is a benign bile duct disease that was first reported 2003. Pathologically, it is characterized by lymphoplasmacytic infiltration with multiple lymphoid follicle formations under the mucosal layer of th
Externí odkaz:
https://doaj.org/article/7cc1df1db22a4e78bacc8ed9f5df19dc